Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
by
Horvath, Gabriella
, Sheffer, Ruth
, Douiev, Liza
, Saada, Ann
in
Adenosine Triphosphate - biosynthesis
/ bezafibrate
/ Bezafibrate - pharmacology
/ Cell Proliferation - drug effects
/ Cell Survival - drug effects
/ dnm1l
/ drp1
/ Dynamins - deficiency
/ Dynamins - metabolism
/ fibroblast
/ Fibroblasts - drug effects
/ Fibroblasts - metabolism
/ Fibroblasts - pathology
/ Humans
/ Male
/ Membrane Potential, Mitochondrial - drug effects
/ mitochondrial disease
/ Mitochondrial Dynamics - drug effects
/ mitochondrial fission-fusion
/ Mutation - genetics
/ Oxygen Consumption - drug effects
/ Reactive Oxygen Species - metabolism
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
by
Horvath, Gabriella
, Sheffer, Ruth
, Douiev, Liza
, Saada, Ann
in
Adenosine Triphosphate - biosynthesis
/ bezafibrate
/ Bezafibrate - pharmacology
/ Cell Proliferation - drug effects
/ Cell Survival - drug effects
/ dnm1l
/ drp1
/ Dynamins - deficiency
/ Dynamins - metabolism
/ fibroblast
/ Fibroblasts - drug effects
/ Fibroblasts - metabolism
/ Fibroblasts - pathology
/ Humans
/ Male
/ Membrane Potential, Mitochondrial - drug effects
/ mitochondrial disease
/ Mitochondrial Dynamics - drug effects
/ mitochondrial fission-fusion
/ Mutation - genetics
/ Oxygen Consumption - drug effects
/ Reactive Oxygen Species - metabolism
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
by
Horvath, Gabriella
, Sheffer, Ruth
, Douiev, Liza
, Saada, Ann
in
Adenosine Triphosphate - biosynthesis
/ bezafibrate
/ Bezafibrate - pharmacology
/ Cell Proliferation - drug effects
/ Cell Survival - drug effects
/ dnm1l
/ drp1
/ Dynamins - deficiency
/ Dynamins - metabolism
/ fibroblast
/ Fibroblasts - drug effects
/ Fibroblasts - metabolism
/ Fibroblasts - pathology
/ Humans
/ Male
/ Membrane Potential, Mitochondrial - drug effects
/ mitochondrial disease
/ Mitochondrial Dynamics - drug effects
/ mitochondrial fission-fusion
/ Mutation - genetics
/ Oxygen Consumption - drug effects
/ Reactive Oxygen Species - metabolism
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
Journal Article
Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Mitochondria are involved in many cellular processes and their main role is cellular energy production. They constantly undergo fission and fusion, and these counteracting processes are under strict balance. The cytosolic dynamin-related protein 1, Drp1, or dynamin-1-like protein (DNM1L) mediates mitochondrial and peroxisomal division. Defects in the DNM1L gene result in a complex neurodevelopmental disorder with heterogeneous symptoms affecting multiple organ systems. Currently there is no curative treatment available for this condition. We have previously described a patient with a de novo heterozygous c.1084G>A (p.G362S) DNM1L mutation and studied the effects of a small molecule, bezafibrate, on mitochondrial functions in this patient’s fibroblasts compared to controls. Bezafibrate normalized growth on glucose-free medium, as well as ATP production and oxygen consumption. It improved mitochondrial morphology in the patient’s fibroblasts, although causing a mild increase in ROS production at the same time. A human foreskin fibroblast cell line overexpressing the p.G362S mutation showed aberrant mitochondrial morphology, which normalized in the presence of bezafibrate. Further studies would be needed to show the consistency of the response to bezafibrate, possibly using fibroblasts from patients with different mutations in DNM1L, and this treatment should be confirmed in clinical trials. However, taking into account the favorable effects in our study, we suggest that bezafibrate could be offered as a treatment option for patients with certain DNM1L mutations.
Publisher
MDPI,MDPI AG
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.